Watch: What to Do About the Vaccine Surplus in the U.S.
By Suresh Acharya, Professor of Practice in the Robert H. Smith School of Business at the University of Maryland, addresses the excess of COVID-19 vaccine doses in the U.S., and what to do about it.
Suresh Acharya, Professor of Practice in the Robert H. Smith School of Business at the University of Maryland, addresses the excess of COVID-19 vaccine doses in the U.S., and what to do about it.Read More
